Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Observational Study Evaluating the Prevalence of Adenosine Deaminase (ADA) Enzyme Deficiency Disease in Lymphopenic Patients in Immunology Clinics

NCT05300334 is registered in ClinicalTrials.gov with TRPHARM as lead sponsor.

NCT NCT05300334
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05300334 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Observational Study Evaluating the Prevalence of Adenosine Deaminase (ADA) Enzyme Deficiency Disease in Lymphopenic Patients in Immunology Clinics
Lead sponsor
TRPHARM
Phase
Observational
Overall status
Unknown status
Start date
October 10, 2019
Completion date
October 10, 2022
Enrollment
800 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adenosine deaminase deficiency